Next Article in Journal
Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer
Next Article in Special Issue
Cumulative Epigenetic Abnormalities in Host Genes with Viral and Microbial Infection during Initiation and Progression of Malignant Lymphoma/Leukemia
Previous Article in Journal
Interaction of Stellate Cells with Pancreatic Carcinoma Cells
Previous Article in Special Issue
Epigenetic Therapy in Human Choriocarcinoma
Article Menu

Export Article

Open AccessArticle
Cancers 2010, 2(3), 1689-1704;

DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes

School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore
Author to whom correspondence should be addressed.
Received: 29 July 2010 / Revised: 23 August 2010 / Accepted: 8 September 2010 / Published: 16 September 2010
(This article belongs to the Special Issue Epigenetics of Cancer Progression)
Full-Text   |   PDF [360 KB, uploaded 17 September 2010]   |  


Deleted in Lung and Esophageal Cancer 1 (DLEC1) is a functional tumor suppressor gene (TSG). It has been found to be silenced in a variety of human cancers including hepatocellular carcinoma (HCC). The silencing of DLEC1 can be modulated by epigenetic modifications, such as DNA hypermethylation and histone hypoacetylation. In the case of HCC, hepatitis B virus X protein (HBx) has been implicated in methylation of target promoters resulting in the down-regulation of tumor suppressor genes, which in turn contributes to the development of HCC. In the present study, we first established a cell system in which epigenetic modifications can be modulated using inhibitors of either DNA methylation or histone deacetylation. The cell system was used to reveal that the expression of DLEC1 was upregulated by HBx in a genotype-dependent manner. In particular, HBx genotype A was found to decrease DNA methylation of the DLEC1 promoter. Our results have provided new insights on the impact of HBx in HCC development by epigenetic modifications. View Full-Text
Keywords: DLEC1; HBV; HBx; DNA methylation; histone acetylation DLEC1; HBV; HBx; DNA methylation; histone acetylation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Niu, D.; Feng, H.; Chen, W.N. DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes. Cancers 2010, 2, 1689-1704.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top